400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2017-03-23
BioClin Therapeutics Inc
临床阶段药物开发商
医药研发/制造
化学&生物药
Sofinnova Partners;
Sofinnova Partners;
Tekla Capital Management;
Tekla Capital Management;
Ysios Capital Partners;
Life Sciences Partners;
HealthCap
2016-01-21
BioClin Therapeutics Inc
临床阶段药物开发商
医药研发/制造
化学&生物药
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10